← Top Holdings
CRNXCrinetics Pharmaceuticals In
CUSIP: 22663K107
No superinvestors currently hold this stock.
📊 Fundamentals
Market Cap$8.9B
Forward P/E-20.6x
EPS (TTM)$-5.14
Revenue (TTM)$18.1M
Profit Margin0.00%
Beta0.23
52-Week Range
$25.83
$84.00
Current: $83.73
Data from Yahoo Finance · refreshed every 4 hours
📊 Holdings Over Time
How superinvestor ownership has changed across quarters
Quarter-by-Quarter Activity
Q4 '241 owners · $6.3M
Q3 '241 owners · $15.8M
No changes
Q2 '241 owners · $13.8M
No changes
Q1 '241 owners · $14.5M
No changes
💰 DCF Calculator
DCF model · 10-yr forecastEstimates depend entirely on your assumptions. Adjust the inputs below to explore scenarios.
⚠️ This company currently has negative free cash flow. The valuation assumes it will improve.
📊 Adjust the assumptions below to calculate an estimated fair value
Projection Period
Revenue Growth Rate
100%analyst est. 151.4%
0%100%
Growth Decay Rate
15%
0% (no decay)50% (fast decay)
Terminal Growth Rate
3.0%
0%5%
FCF Margin
5.0%current: -1340.1%
1%50%
Discount Rate (WACC)
8.0%typical: 8% large caps · 10% growth
5%20%
Model: 10-year DCF · 3.0% terminal growth · Based on Yahoo Finance data
🏛️ Congressional Trades
CRNX: Held by 0 superinvestors · 4 congress member trades
$1,001 - $15,0002026-03-03
$1,001 - $15,0002025-04-17
$1,001 - $15,0002025-03-19
$1,001 - $15,0002025-01-29